Correlation Between Bristol Myers and Perrigo Company

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Perrigo Company at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Perrigo Company into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Perrigo Company PLC, you can compare the effects of market volatilities on Bristol Myers and Perrigo Company and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Perrigo Company. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Perrigo Company.

Diversification Opportunities for Bristol Myers and Perrigo Company

0.79

Correlation Coefficient

Bristol Myers  Perrigo Company

Poor diversification

The 3 months correlation between Bristol and Perrigo is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Perrigo Company PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Perrigo Company and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Perrigo Company. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Perrigo Company has no effect on the direction of Bristol Myers i.e., Bristol Myers and Perrigo Company go up and down completely randomly.

Pair Corralation between Bristol Myers and Perrigo Company

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.94 times more return on investment than Perrigo Company. However, Bristol Myers Squibb is 1.06 times less risky than Perrigo Company. It trades about -0.09 of its potential returns per unit of risk. Perrigo Company PLC is currently generating about -0.34 per unit of risk. If you would invest  5,807  in Bristol Myers Squibb on October 9, 2024 and sell it today you would lose (139.00) from holding Bristol Myers Squibb or give up 2.39% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  Perrigo Company PLC

Bristol Myers Squibb

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Perrigo Company

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Perrigo Company PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Perrigo Company is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Bristol Myers and Perrigo Company

The main advantage of trading using opposite Bristol Myers and Perrigo Company positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Perrigo Company can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Perrigo Company will offset losses from the drop in Perrigo Company's long position.

The idea behind Bristol Myers Squibb and Perrigo Company PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.